439 related articles for article (PubMed ID: 16805422)
41. Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction.
Ruggieri MR
Nat Clin Pract Urol; 2006 Apr; 3(4):206-15. PubMed ID: 16607369
[TBL] [Abstract][Full Text] [Related]
42. Purinergic Mechanisms and Pain.
Burnstock G
Adv Pharmacol; 2016; 75():91-137. PubMed ID: 26920010
[TBL] [Abstract][Full Text] [Related]
43. Discovery of purinergic signalling, the initial resistance and current explosion of interest.
Burnstock G
Br J Pharmacol; 2012 Sep; 167(2):238-55. PubMed ID: 22537142
[TBL] [Abstract][Full Text] [Related]
44. [Purinergic signals].
Lazarowski ER; Schwarzbaum PJ
Medicina (B Aires); 2009; 69(2):267-76. PubMed ID: 19435702
[TBL] [Abstract][Full Text] [Related]
45. Painful purinergic receptors.
Donnelly-Roberts D; McGaraughty S; Shieh CC; Honore P; Jarvis MF
J Pharmacol Exp Ther; 2008 Feb; 324(2):409-15. PubMed ID: 18042830
[TBL] [Abstract][Full Text] [Related]
46. Purinergic neuron-to-glia signaling in the enteric nervous system.
Gulbransen BD; Sharkey KA
Gastroenterology; 2009 Apr; 136(4):1349-58. PubMed ID: 19250649
[TBL] [Abstract][Full Text] [Related]
47. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.
Volonté C; D'Ambrosi N
FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212
[TBL] [Abstract][Full Text] [Related]
48. The P2Y(1) and P2Y(12) receptors mediate autoinhibition of transmitter release in sympathetic innervated tissues.
Quintas C; Fraga S; Gonçalves J; Queiroz G
Neurochem Int; 2009 Dec; 55(7):505-13. PubMed ID: 19447154
[TBL] [Abstract][Full Text] [Related]
49. [New targets for drug therapeutics: receptors for purines and pyrimidines].
Ren LM; Zhang M; Yao SK; Zhu ZN
Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):116-20. PubMed ID: 12889142
[TBL] [Abstract][Full Text] [Related]
50. Short- and long-term (trophic) purinergic signalling.
Burnstock G
Philos Trans R Soc Lond B Biol Sci; 2016 Aug; 371(1700):. PubMed ID: 27377731
[TBL] [Abstract][Full Text] [Related]
51. Purinergic substances promote murine keratinocyte proliferation and enhance impaired wound healing in mice.
Braun M; Lelieur K; Kietzmann M
Wound Repair Regen; 2006; 14(2):152-61. PubMed ID: 16630104
[TBL] [Abstract][Full Text] [Related]
52. Purinergic Signalling and Endothelium.
Burnstock G
Curr Vasc Pharmacol; 2016; 14(2):130-45. PubMed ID: 26638799
[TBL] [Abstract][Full Text] [Related]
53. Purinergic signalling in the enteric nervous system (An overview of current perspectives).
King BF
Auton Neurosci; 2015 Sep; 191():141-7. PubMed ID: 26049261
[TBL] [Abstract][Full Text] [Related]
54. Purinergic Signalling and Neurological Diseases: An Update.
Burnstock G
CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
[TBL] [Abstract][Full Text] [Related]
55. Adrenergic receptor activation involves ATP release and feedback through purinergic receptors.
Sumi Y; Woehrle T; Chen Y; Yao Y; Li A; Junger WG
Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1118-26. PubMed ID: 20668211
[TBL] [Abstract][Full Text] [Related]
56. The enteric purinergic P2Y1 receptor.
Wood JD
Curr Opin Pharmacol; 2006 Dec; 6(6):564-70. PubMed ID: 16934527
[TBL] [Abstract][Full Text] [Related]
57. Purinergic receptors and pain.
Burnstock G
Curr Pharm Des; 2009; 15(15):1717-35. PubMed ID: 19442186
[TBL] [Abstract][Full Text] [Related]
58. Expression and function of P2Y receptors on Müller cells of the postnatal rat retina.
Wurm A; Erdmann I; Bringmann A; Reichenbach A; Pannicke T
Glia; 2009 Nov; 57(15):1680-90. PubMed ID: 19373936
[TBL] [Abstract][Full Text] [Related]
59. ALS: focus on purinergic signalling.
Volonté C; Apolloni S; Carrì MT; D'Ambrosi N
Pharmacol Ther; 2011 Oct; 132(1):111-22. PubMed ID: 21704075
[TBL] [Abstract][Full Text] [Related]
60. Purinergic signalling in the pancreas in health and disease.
Burnstock G; Novak I
J Endocrinol; 2012 May; 213(2):123-41. PubMed ID: 22396456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
